{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:20:48Z","timestamp":1787779248292,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.alit.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:51:01Z","timestamp":1787777461000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transgenic rice-based peptide immunotherapy for Japanese cedar pollinosis: From T-cell epitope discovery to clinical translation"],"prefix":"10.1016","author":[{"given":"Ryoto","family":"Mitsuyoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhya","family":"Wakasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Otori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2026.07.010_bib1","first-page":"16","article-title":"Japanese cedar pollinosis in nikko, Japan","volume":"13","author":"Horiguchi","year":"1964","journal-title":"Jpn J Allergol"},{"key":"10.1016\/j.alit.2026.07.010_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaci.2013.11.002","article-title":"Present state of Japanese cedar pollinosis: the national affliction","volume":"133","author":"Yamada","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib3","first-page":"7","article-title":"Willingness to pay and quality of life in patients with japanese-cedar pollinosis","volume":"52","author":"Kakutani","year":"2003","journal-title":"Arerugi"},{"key":"10.1016\/j.alit.2026.07.010_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/pai.12660","article-title":"The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a paediatric assessment","volume":"28","author":"Rodr\u00edguez Del R\u00edo","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib6","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"1","author":"Noon","year":"1911","journal-title":"Lancet."},{"issue":"6 Pt 1","key":"10.1016\/j.alit.2026.07.010_bib7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1164\/ajrccm.154.6.8970345","article-title":"Treatment of cat allergy with T-cell reactive peptides","volume":"154","author":"Norman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2026.07.010_bib8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1586\/1744666X.2015.1066673","article-title":"SPIREs: a new horizon for allergic disease treatment?","volume":"11","author":"Worm","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nri824","article-title":"The future of antigen-specific immunotherapy of allergy","volume":"2","author":"Valenta","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/all.15966","article-title":"Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy","volume":"79","author":"Voskamp","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.07.010_bib11","unstructured":"ClinicalTrials.gov identifier: NCT05621317."},{"key":"10.1016\/j.alit.2026.07.010_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1067\/mai.2001.115481","article-title":"Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major JC pollen allergens","volume":"108","author":"Hirahara","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1467-7652.2005.00143.x","article-title":"Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine","volume":"3","author":"Takagi","year":"2005","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.alit.2026.07.010_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2217\/imt.13.4","article-title":"Update on the use of transgenic rice seeds in oral immunotherapy","volume":"5","author":"Takaiwa","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.alit.2026.07.010_bib15","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2026.07.010_bib16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jaci.2016.08.017","article-title":"Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults","volume":"139","author":"Jones","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2567.2002.01534.x","article-title":"Three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen antigens, retain their immunogenicity and tolerogenicity in a linked peptide","volume":"107","author":"Yoshitomi","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.alit.2026.07.010_bib18","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.1073\/pnas.0503428102","article-title":"A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses","volume":"102","author":"Takagi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6 Pt 1","key":"10.1016\/j.alit.2026.07.010_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0091-6749(98)70334-3","article-title":"Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cry j 2-primed mice","volume":"102","author":"Hirahara","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib20","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1021\/jf900371u","article-title":"26-Week oral safety study in macaques for transgenic rice containing major human T-cell epitope peptides from JC pollen allergens","volume":"57","author":"Domon","year":"2009","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.alit.2026.07.010_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000509996","article-title":"Immunological and symptomatic effects of oral intake of transgenic rice containing 7 linked major T-Cell epitopes from Japanese cedar pollen allergens","volume":"182","author":"Endo","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2500\/aap.2021.42.210011","article-title":"Long-term oral administration of transgenic rice containing cedar pollen T-cell epitopes potentially improves medication- and allergy-related quality-of-life scores","volume":"42","author":"Endo","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.alit.2026.07.010_bib23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","article-title":"Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study","volume":"126","author":"Marogna","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.07.010_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.intimp.2014.01.030","article-title":"Peptide based immunotherapy: a pivotal tool for allergy treatment","volume":"19","author":"Gupta","year":"2014","journal-title":"Int Immunopharmacol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893026000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893026000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:51:05Z","timestamp":1787777465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893026000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"alternative-id":["S1323893026000948"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2026.07.010","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transgenic rice-based peptide immunotherapy for Japanese cedar pollinosis: From T-cell epitope discovery to clinical translation","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}